Stevanato Group S.p.A. (STVN) Insider Flynn Buys 4,975 Shares
Insider Karen Flynn purchased 4,975 shares of Stevanato Group on June 12, 2026, as the stock trades below its recent highs.
Reviewed by automated data checks against the source filing. How we make and check alerts
Karen Flynn bought 4,975 shares of Stevanato Group S.p.A. ($STVN) on June 12, 2026. The trade was reported to the SEC in a Form 4 filing.
Since the trade, $STVN is down 0.8% after 1 week, up 15.8% after 1 month and up 10.7% to date (from the $17.08 close on Jun 12, 2026).
Key Points
- Karen Flynn bought 4,975 shares of Stevanato Group S.p.A. (NYSE: STVN) on June 12, 2026, valuing the purchase at approximately $91,500 based on the current share price of $18.39.
- The stock is currently trading below its 50-day moving average of $20.98, indicating a potential opportunity for insiders to buy at a lower price.
- Analysts maintain a Neutral rating on Stevanato Group with a price target of $23.00, down from a previous target of $28.00, reflecting mixed sentiment.
Get $STVN trade alerts by text
We text you when insiders, Congress or big funds trade $STVN. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Stevanato Group S.p.A. alert may contain errors. Disclosures
Insider Buying and Selling at Stevanato Group S.p.A.
On June 12, 2026, Karen Flynn, an insider at Stevanato Group S.p.A. (NYSE: STVN), bought 4,975 shares of the company. This purchase is valued at approximately $91,500, based on the current share price of $18.39. This transaction comes as the stock sits below its recent highs, creating a potential buying opportunity for insiders.
Recent Insider Transactions
Flynn's purchase adds to a series of insider trades at Stevanato Group. On the same day, two other insiders, Elisabetta Magistretti and Madhavan Balachandran, also acquired 4,975 shares each. This pattern of insider buying suggests confidence in the company's future. Earlier, on June 9, Mauro Stocchi, the Chief Business Strategy Officer, bought 6,586 shares, further indicating ongoing insider interest in the stock.
How Stevanato Group S.p.A. Stock Has Traded
Stevanato Group's shares are currently trading at $18.39, which is below its 50-day moving average of $20.98. The stock has a 52-week range between $12.89 and $27.99, highlighting its volatility. This positioning below the moving average may attract more insider buying as they look to capitalize on lower prices.
Analysts Set New Price Targets
On September 9, 2026, UBS maintained a Neutral rating on Stevanato Group with a price target of $23.00, down from a previous target of $28.00. This change reflects a cautious outlook from analysts, with the consensus recommending a hold on the stock. Currently, 13 analysts have provided opinions, and the average target price suggests some room for growth from current levels.
What Stevanato Group S.p.A. Does
Stevanato Group S.p.A. specializes in designing and manufacturing products for the biopharma and healthcare industries. Its offerings include drug containment solutions and drug delivery systems used by pharmaceutical and biotechnology companies globally. The recent insider purchases may signal confidence in the company's ongoing projects and market position.
What's Ahead for Stevanato Group S.p.A.
Investors will be watching for further insider activity and the upcoming earnings report scheduled for November 5, 2026. It's important to note that these insider transactions reflect positions as of their respective dates, and the recent trades may not represent current holdings. With analysts maintaining a Neutral rating, the stock's performance in the coming months will be closely scrutinized.
Source: Karen Flynn's Form 4 filing on $STVN (Jun 12, 2026). Find the original filing: STVN Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts
